152 related articles for article (PubMed ID: 36000446)
21. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract][Full Text] [Related]
22. Detection of human papillomavirus DNA in primary and metastatic lesions of carcinoma of the cervix in women from Okinawa, Japan.
Nagai Y; Maehama T; Asato T; Kanazawa K
Am J Clin Oncol; 2001 Apr; 24(2):160-6. PubMed ID: 11319292
[TBL] [Abstract][Full Text] [Related]
23. Causes of cervical cancer in the Philippines: a case-control study.
Ngelangel C; Muñoz N; Bosch FX; Limson GM; Festin MR; Deacon J; Jacobs MV; Santamaria M; Meijer CJ; Walboomers JM
J Natl Cancer Inst; 1998 Jan; 90(1):43-9. PubMed ID: 9428782
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
[TBL] [Abstract][Full Text] [Related]
25. Correlation of human papillomavirus 16 and 18 with cervical neoplasia in histological typing and clinical stage in Taiwan: an in-situ polymerase chain reaction approach.
Shyu JS; Chen CJ; Chiu CC; Huang SC; Harn HJ
J Surg Oncol; 2001 Oct; 78(2):101-9. PubMed ID: 11579387
[TBL] [Abstract][Full Text] [Related]
26. Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix.
Minaguchi T; Yoshikawa H; Nakagawa S; Yasugi T; Yano T; Iwase H; Mizutani K; Shiromizu K; Ohmi K; Watanabe Y; Noda K; Nishiu M; Nakamura Y; Taketani Y
Cancer Lett; 2004 Jul; 210(1):57-62. PubMed ID: 15172121
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of KRAS and its clinical implications in cervical cancer patients.
Jiang W; Xiang L; Pei X; He T; Shen X; Wu X; Yang H
J Gynecol Oncol; 2018 Jan; 29(1):e4. PubMed ID: 29185262
[TBL] [Abstract][Full Text] [Related]
28. [In situ hybridization study on the detection of HPV DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix].
Fujimoto H; Nagai N; Kioka H; Ohta S; Tanimoto H; Fujiwara A
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jun; 43(6):589-94. PubMed ID: 1649879
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses.
Giannoudis A; Herrington CS
Cancer; 2000 Sep; 89(6):1300-7. PubMed ID: 11002226
[TBL] [Abstract][Full Text] [Related]
30. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature.
Masand RP; El-Mofty SK; Ma XJ; Luo Y; Flanagan JJ; Lewis JS
Head Neck Pathol; 2011 Jun; 5(2):108-16. PubMed ID: 21305368
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of HPV physical status and integration sites in cervical cancer.
Nambaru L; Meenakumari B; Swaminathan R; Rajkumar T
Asian Pac J Cancer Prev; 2009; 10(3):355-60. PubMed ID: 19640172
[TBL] [Abstract][Full Text] [Related]
32. Detection of oncogenic HPV DNA by a consensus polymerase chain reaction method in genital carcinomas in twenty women in Barbados.
Prussia PR; ter Schegget J; Smits HL
West Indian Med J; 1993 Dec; 42(4):144-6. PubMed ID: 8160454
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus detection in adenocarcinoma and adenosquamous carcinoma of the uterine cervix in Taiwan.
Tseng HH; Wang JS; Kan YY
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):47-53. PubMed ID: 8820036
[TBL] [Abstract][Full Text] [Related]
34. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases.
Wang TY; Chen BF; Yang YC; Chen H; Wang Y; Cviko A; Quade BJ; Sun D; Yang A; McKeon FD; Crum CP
Hum Pathol; 2001 May; 32(5):479-86. PubMed ID: 11381365
[TBL] [Abstract][Full Text] [Related]
35. DEK overexpression in uterine cervical cancers.
Wu Q; Li Z; Lin H; Han L; Liu S; Lin Z
Pathol Int; 2008 Jun; 58(6):378-82. PubMed ID: 18477217
[TBL] [Abstract][Full Text] [Related]
36. HPV+ cervical carcinomas and cell lines display altered expression of caspases.
Aréchaga-Ocampo E; Pereira-Suárez AL; del Moral-Hernández O; Cedillo-Barrón L; Rodríguez-Sastre MA; Castillo-Alvarez A; López-Bayghen E; Villegas-Sepúlveda N
Gynecol Oncol; 2008 Jan; 108(1):10-8. PubMed ID: 17936882
[TBL] [Abstract][Full Text] [Related]
37. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
[TBL] [Abstract][Full Text] [Related]
38. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
39. Co-expression of p53 and Bcl-2 proteins in human papillomavirus-induced premalignant lesions of the uterine cervix: correlation with progression to malignancy.
Singh M; Srivastava S; Singh U; Mathur N; Shukla Y
Tumour Biol; 2009; 30(5-6):276-85. PubMed ID: 19940548
[TBL] [Abstract][Full Text] [Related]
40. Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma.
Yoshida T; Sano T; Oyama T; Kanuma T; Fukuda T
Virchows Arch; 2009 Sep; 455(3):253-9. PubMed ID: 19727809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
